Q4 2024 Earnings Call Transcript January 28, 2025 Operator: Good afternoon, and welcome to the Alexandria Real Estate ...

The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Delving into the details, we found 51% of traders were bullish, while 25% showed bearish tendencies. Out of all the trades we ...

Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product ...

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...

MSD and partner Moderna have started a late-stage trial of their personalised cancer vaccine V940 as a combination with MSD’s PD-1 inhibitor Keytruda for patients with non-small cell lung cancer ...

Record revenue of €4.57bn in 2024, up +6.1% vs. 2023 Estimated 2024 financial results meet communicated targets: Adjusted EBITDA at c. 35.2%Free cash flow slightly above €340m 2024 revenue at €4,573.7 ...

2-Year U.S. Treasury Note Continuous Contract $102.781-0.031-0.03% 5-Year U.S. Treasury Note Continuous Contract $106.375-0.016-0.01% 10-Year U.S. Treasury Note Continuous Contract $108.875 0.031 ...

Recent and archival articles, essays, photographs, videos, infographics, writing prompts, lesson plans and more. By The Learning Network We asked students, “What are you thinking and feeling ...

Real time quote data is not available at this time. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.